Page 5 - HFA_Dateline_2019_Q2_Summer
P. 5

Creating the path for
advancements in hemophilia
gene therapy research

                                                                      Join us at
                                                            HemophiliaForward.com

Spark Therapeutics has created                               For residents of the U.S. only
a place for patients and caregivers
TO LEARN ABOUT THE SCIENCE OF
GENE THERAPY RESEARCH, which
is being investigated for hemophilia.

“It is incredible to think of what a transformative          “My career has been focused on delivering
 advance gene therapy could be—it has been                   cutting-edge medical care for patients with
 my career focus for the past two decades                    hemophilia. I’m excited that gene therapy
 to solve this challenge.”                                   could potentially be brought to people I have
                                                             cared deeply about for so many years.”
 Katherine A. High, MD, president and chief scientific o cer
                                                             Leonard Valentino, MD, medical strategy lead, hematology

© 2018 Spark Therapeutics, Inc.
Hemophilia Forward is sponsored by Spark Therapeutics, Inc.
1-855-SPARKTX

                                                                                   N-HEM-US-420016
   1   2   3   4   5   6   7   8   9   10